Skip to main content

CORRECTION article

Front. Immunol., 13 May 2021
Sec. Viral Immunology
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.700716

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome

Jose Alberto Choreño-Parra1,2 Luis Armando Jiménez-Álvarez2 Gustavo Ramírez-Martínez2 Montserrat Sandoval-Vega3 Citlaltepetl Salinas-Lara4 Carlos Sánchez-Garibay4 Cesar Luna-Rivero5 Erika Mariana Hernández-Montiel2,6 Luis Alejandro Fernández-López1,2 María Fernanda Cabrera-Cornejo2,6 Eduardo Misael Choreño-Parra7 Alfredo Cruz-Lagunas2 Andrea Domínguez2,6 Eduardo Márquez-García2 Carlos Cabello-Gutiérrez8 Francina Valezka Bolaños-Morales9 Lourdes Mena-Hernández10 Diego Delgado-Zaldivar10 Daniel Rebolledo-García10 Parménides Guadarrama-Ortiz11 Nora E. Regino-Zamarripa1,2,6 Criselda Mendoza-Milla12 Ethel A. García-Latorre1 Tatiana Sofía Rodríguez-Reyna13 Diana Cervántes-Rosete13 Carmen M. Hernández-Cárdenas14 Shabaana A. Khader15 Albert Zlotnik16 Joaquín Zúñiga2,6*
  • 1Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico
  • 2Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico
  • 3Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Mexico City, Mexico
  • 4Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suarez”, Mexico City, Mexico
  • 5Department of Pathology, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico
  • 6Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico
  • 7Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico
  • 8Department of Virology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
  • 9Subdirection of Surgery, Instituto Nacional deEnfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
  • 10Departments of Dermatology and Education, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • 11Centro Especializado en Neurocirugía y Neurociencias México (CENNM), Mexico City, Mexico
  • 12Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico
  • 13Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • 14Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
  • 15Department of Molecular Microbiology, Washington University School of Medicine in St Louis, St. Louis, MO, United States
  • 16Department of Physiology & Biophysics School of Medicine, Institute for Immunology, University of California, Irvine, CA, United States

A Corrigendum on
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome

By Choreño-Parra JA, Jiménez-Álvarez LA, Ramírez-Martínez G, Sandoval-Vega M, Salinas-Lara C, Sánchez-Garibay C, Luna-Rivero C, Hernández-Montiel EM, Fernández-López LA, Cabrera-Cornejo MF, Choreño-Parra EM, Cruz-Lagunas A, Domínguez A, Márquez-García E, Cabello-Gutiérrez C, Bolaños-Morales FV, Mena-Hernández L, Delgado-Zaldivar D, Rebolledo-García D, Guadarrama-Ortiz P, Regino-Zamarripa NE, Mendoza-Milla C, García-Latorre EA, Rodríguez-Reyna TS, Cervántes-Rosete D, Hernández Cárdenas CM, Khader SA, Zlotnik A and Zúñiga J (2021). Front. Immunol. 12:633297. doi: .10.3389/fimmu.2021.633297

An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofía Rodríguez-Reyna.

In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico”.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: influenza A(H1N1), SARS-CoV-2, COVID-19, tuberculosis, chemokines, CXCL17

Citation: Choreño-Parra JA, Jiménez-Álvarez LA, Ramírez-Martínez G, Sandoval-Vega M, Salinas-Lara C, Sánchez-Garibay C, Luna-Rivero C, Hernández-Montiel EM, Fernández-López LA, Cabrera-Cornejo MF, Choreño-Parra EM, Cruz-Lagunas A, Domínguez A, Márquez-García E, Cabello-Gutiérrez C, Bolaños-Morales FV, Mena-Hernández L, Delgado-Zaldivar D, Rebolledo-García D, Guadarrama-Ortiz P, Regino-Zamarripa NE, Mendoza-Milla C, García-Latorre EA, Rodríguez-Reyna TS, Cervántes-Rosete D, Hernández-Cárdenas CM, Khader SA, Zlotnik A and Zúñiga J (2021) Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome. Front. Immunol. 12:700716. doi: 10.3389/fimmu.2021.700716

Received: 26 April 2021; Accepted: 27 April 2021;
Published: 13 May 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Choreño-Parra, Jiménez-Álvarez, Ramírez-Martínez, Sandoval-Vega, Salinas-Lara, Sánchez-Garibay, Luna-Rivero, Hernández-Montiel, Fernández-López, Cabrera-Cornejo, Choreño-Parra, Cruz-Lagunas, Domínguez, Márquez-García, Cabello-Gutiérrez, Bolaños-Morales, Mena-Hernández, Delgado-Zaldivar, Rebolledo-García, Guadarrama-Ortiz, Regino-Zamarripa, Mendoza-Milla, García-Latorre, Rodríguez-Reyna, Cervántes-Rosete, Hernández-Cárdenas, Khader, Zlotnik and Zúñiga. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Joaquín Zúñiga, joazu@yahoo.com

Download